取得学位・資格
学士(心理学専攻)、修士(心理学専攻)、MS(International Health)、PhD(Biostatistics-Epidemiology)
ResearchGate/LinkedInアカウント
Research Gate:https://www.researchgate.net/profile/Ryuichi-Komatsu-2
LinkedIn:www.linkedin.com/in/ryuichikomatsu
他所属
School of Tropical Medicine & Global Health
経歴
Education
- PhD (Epidemiology). University of Hawaii at Manoa, Honolulu, USA.
- MS (International Health). University of Hawaii at Manoa, Honolulu, USA.
- MA (Psychology). Waseda University. Tokyo, Japan.
- BA (Psychology). Waseda University, Tokyo, Japan.
Professions
- Independent Consultant (2023-).
- WHO, Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, Geneva, Switzerland (2023).
- The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland (2005-2023).
- SILAIS-JICA, Granada, Nicaragua (short term experts, 2002-2004).
- National Institute of Population and Social Security Research, Tokyo, Japan (1999-2005).
- UNAIDS, Geneva, Switzerland (1997).
- East-West Center, Program on Population, Honolulu, Hawaii, USA (1994-1999).
- Thai Red Cross Society, Program on AIDS, Bangkok, Thailand (1994-1998).
教育活動
- Kyoto University
研究活動・実務経験
-
- Global Health governance and diplomacy: Facilitated decision making with evidence.
- Evaluation: Various aspects of the Global Fund. Contribution to framework document for malaria impact evaluation as well as HIV and malaria program reviews and evaluations in Asian and African countries.
- Strategy and policy development: Development of various organizational policies, e.g., operational policies and procedures, human resources, etc. Convener of workstreams to develop a Global Fund Strategy. Strategic shift of Global Fund investment in parallel data system to national HIS.
- Donor coordination/alignment and private sector engagement: The Future of Global Health Initiatives and the Lusaka Agenda. Results harmonization for the Global Fund, PEPFAR, WHO, UNAIDS, and UNDP. Donor coordination on strengthening national health information systems to enhance impact measurement and on program reviews. Advice and support for NGOs and private sector companies.
- Health Information systems/ strategic information: Technical support for HIS and strategic information for Asian and African countries. Contribution to guidance documents for UNAIDS and WHO. Estimation of HIV burden in various countries and modeling of lives saved by Global Fund-supported programs. Development of the results data system for the Global Fund and corporate results reports.
- Infectious diseases: Research as well as expert groups/committees related to HIV, TB and malaria. Global and regional workshops on programmatic mapping and size estimation for key populations.
- Management: of multicultural, multidisciplinary teams; governance mechanisms; partnerships as well as donor relations. KPI development and reporting.
最近の5つの出版物
-
- Martinez-Vega R, Ishengoma DS, Gosling R, Rosenthal PJ, Dondorp A, Barnes KI, Nsanzabana C, Djimde AA, Ochola-Oyier LI, Tibenderana J, Chimumbwa J, Golassa L, Kapologwe NA, Mbacham WF, Kamya MR, Fidock DA, Komatsu R, von Seidlein L, Dhorda M. Regional action needed to halt antimalarial drug resistance in Africa. Lancet. 2025 Jan 4;405(10472):7-10.
- Dhorda M, Kaneko A, Komatsu R, et al. Artemisinin-resistant malaria in Africa demands urgent action. Science. 2024 Jul 19;385(6706):252-254.
- Hershey CL, Bhattarai A, Florey LS, McElroy PD, Nielsen CF, Yé Y, Eckert E, Franca-Koh AC, Shargie E, Komatsu R, et al. Implementing Impact Evaluations of Malaria Control Interventions: Process, Lessons Learned, and Recommendations. Am J Trop Med Hyg 2017 Sep;97 (3_Suppl):20-31.
- Yé Y, Eisele TP, Eckert E, Korenromp E, Shah JA, Hershey CL, Ivanovich E, Newby H, Carvajal-Velez L, Lynch M, Komatsu R, et al. Framework for Evaluating the Health Impact of the Scale-Up of Malaria Control Interventions on All-Cause Child Mortality in Sub Saharan Africa. Am J Trop Med Hyg 2017 Sep;97(3_Suppl):9-19.
- Consolidated guidelines on person-centred viral hepatitis strategic information: Data to support the country scale-up of hepatitis prevention, diagnosis and treatment services. WHO. 2024.